VSTM

Verastem's stock experienced several events and fluctuations over the past six months. In November 2025, its market capitalization was approximately $610.7 million, with the stock priced at $9.81 per share, reflecting a 149.62% increase over the prior year. The company reported net product revenue of $11.2 million in Q3 2025. In February 2026, Verastem announced preliminary Q4 and full-year 2025 net product revenues, reporting approximately $17.5 million for Q4 and $30.9 million for the full year. On March 4, 2026, Verastem reported its full Q4 and full-year 2025 financial results. On May 7, 2026, Verastem reported Q1 2026 financial results, with net product revenue of $18.7 million. The stock price has shown volatility, with a 52-week range between $4.01 and $11.25. As of May 6, 2026, the share price was $6.01, representing a 10.16% decline over the past year. Shareholders have experienced substantial dilution, with a 91% increase in shares outstanding, and there has been significant insider selling.